Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Sep 28 - Oct 3
Morgenstern, R., Zhang, J
In 2023, the market was valued at approximately US $3.6 billion, and it is projected to reach $6.2 billion by 2030, representing a compound annual growth rate (CAGR) of approximately 8% during the forecast period (20242030) [8]
Crucially, its enhanced metabolic stability and superior bioavailability enable it to readily traverse the blood-brain barrier, surpassing the therapeutic limitations of its parent molecule
That means ruling out celiac disease, anemia, bleeding, and true IBD
US$ 25.27
US$ 27.49
US$ 21.50
US$ 22.72
US$ 25.19
US$ 23.69
US$ 29.95
